Ovarian Cancer Pipeline Market 2016 Global Review Covering 271 Companies

Pune India - July 29, 2016 /MarketersMEDIA/ —

Ovarian Cancer Pipeline Market Companies Involved in Therapeutics Development are 3-V Biosciences, Inc. ,4SC AG ,AB Science SA ,AbbVie Inc. ,AbGenomics International, Inc. ,Acetylon Pharmaceuticals, Inc. ,Adaptimmune Therapeutics Plc ,Adgero Biopharmaceuticals, Inc. ,Aduro BioTech, Inc. ,Advanced Accelerator Applications S.A. ,Advantagene, Inc. ,Advaxis, Inc. ,Advenchen Laboratories, LLC ,Aeterna Zentaris Inc. ,Alchemia Limited ,Alethia Biotherapeutics Inc. ,Almac Discovery Limited ,Alpha Cancer Technologies Inc. ,Alteogen Inc. ,Ambrx, Inc. ,Amgen Inc. ,Anavex Life Sciences Corp. ,ANP Technologies, Inc. ,Antoxis Limited ,Apac Biotech Pvt Ltd ,Aphios Corporation ,Aposense Ltd. ,Aprea AB ,arGEN-X BV ,Armour Therapeutics Inc. ,Arno Therapeutics, Inc. ,Arog Pharmaceuticals, Inc. ,ArQule, Inc. ,Arrien Pharmaceuticals, LLC ,Arvinas, Inc. ,Ascentage Pharma Group Corporation, Ltd. ,Astellas Pharma Inc. ,Astex Pharmaceuticals, Inc. ,AstraZeneca Plc ,Atara Biotherapeutics, Inc. ,ATLAB Pharma SAS ,AVEO Pharmaceuticals, Inc. ,Avipep Pty Ltd ,Azaya Therapeutics, Inc. ,Basilea Pharmaceutica AG ,Bavarian Nordic A/S ,Bayer AG ,BeiGene, Ltd. ,BioCancell Ltd ,BioMoti Limited ,BioNTech AG ,BioNumerik Pharmaceuticals, Inc. ,Bioo Therapeutics ,Biscayne Pharmaceuticals, Inc. ,Boehringer Ingelheim GmbH ,Boston Biomedical, Inc. ,Bristol-Myers Squibb Company ,Calithera Biosciences, Inc. ,CASI Pharmaceuticals Inc. ,Cavion LLC ,Cellceutix Corporation ,Celldex Therapeutics, Inc. ,Cellectar Biosciences, Inc. ,Cellular Biomedicine Group, Inc. ,Celon Pharma Sp. z o.o. ,Celprogen, Inc. ,Celsion Corporation ,Celyad SA ,Ceronco Biosciences ,CerRx, Inc. ,Cerulean Pharma, Inc. ,Chikujee Therapeutics ,Chipscreen Biosciences Ltd ,Clovis Oncology, Inc. ,CohBar, Inc. ,Coherus BioSciences, Inc. ,Commence Bio, Inc. ,Compliment Corporation ,Corcept Therapeutics Incorporated ,Critical Outcome Technologies Inc. ,CritiTech, Inc. ,CTI BioPharma Corp. ,Cyclacel Pharmaceuticals, Inc. ,CytRx Corporation ,CZ BioMed Corp ,Debiopharm International SA ,Deciphera Pharmaceuticals, LLC ,DEKK-TEC, Inc. ,DelMar Pharmaceuticals, Inc. ,Dr. Reddy's Laboratories Limited ,EirGenix Inc. ,Eisai Co., Ltd. ,Eli Lilly and Company ,Endocyte, Inc. ,EntreChem, S.L. ,Epigen Biosciences, Inc. ,Esperance Pharmaceuticals, Inc. ,Exelixis, Inc. ,F. Hoffmann-La Roche Ltd. ,Fate Therapeutics, Inc. ,Forty Seven Inc. ,Fujifilm Corporation ,Galena Biopharma, Inc. ,GamaMabs Pharma S.A. ,Ganymed Pharmaceuticals AG ,Gene Techno Science Co., Ltd. ,Genelux Corporation ,Genentech, Inc. ,Generex Biotechnology Corporation ,Genisphere Inc. ,Genmab A/S ,Genor BioPharma Co., Ltd. ,Gero Corp ,Gilead Sciences, Inc. ,GlaxoSmithKline Plc ,Glenmark Pharmaceuticals Ltd. ,GlycoNex Inc. ,Glycotope GmbH ,GP Pharm, S.A. ,Gradalis Inc. ,GW Pharmaceuticals Plc ,Halozyme Therapeutics, Inc. ,HEC Pharm Co., Ltd. ,Hemispherx Biopharma, Inc. ,Horizon Pharma Plc ,Ideaya Biosciences Inc ,Ignyta, Inc. ,IMMD Inc. ,Immune Design Corp. ,Immune Pharmaceuticals Inc. ,ImmunoFrontier, Inc. ,ImmunoGen, Inc. ,Immunomedics, Inc. ,Immunovaccine, Inc. ,Incyte Corporation ,Inflection Biosciences Limited ,Innate Immunotherapeutics Ltd ,Innate Pharma S.A. ,Inovio Pharmaceuticals, Inc. ,INSYS Therapeutics, Inc. ,Inventiva ,Jiangsu Kanion Pharmaceutical Co., Ltd. ,Johnson & Johnson ,Juno Therapeutics Inc. ,Karyopharm Therapeutics, Inc. ,Komipharm International Co., Ltd. ,Kyowa Hakko Kirin Co., Ltd. ,Laboratoire HRA Pharma ,Lee's Pharmaceutical Holdings Limited ,LegoChem Biosciences, Inc ,Lymphocyte Activation Technologies, S.A. ,Mabion SA ,MabVax Therapeutics Holdings, Inc. ,MacroGenics, Inc. ,Mateon Therapeutics Inc ,MaxiVAX SA ,Mebiopharm Co., Ltd. ,Medestea Research & Production S.p.A. ,MediaPharma s.r.l. ,MedImmune, LLC ,Medivation, Inc. ,MEI Pharma, Inc. ,Merck & Co., Inc. ,Merck KGaA ,Mersana Therapeutics, Inc. ,Merus B.V. ,Midatech Pharma Plc ,Millennium Pharmaceuticals, Inc. ,Minerva Biotechnologies Corporation ,Molecular Partners AG ,MolMed S.p.A. ,Momenta Pharmaceuticals, Inc. ,Monopar Therapeutics LLC ,Morphotek, Inc. ,Mundipharma International Ltd ,Mycenax Biotech Inc. ,Natco Pharma Limited ,Nektar Therapeutics ,Nemucore Medical Innovations, Inc. ,Neovacs SA ,Nerviano Medical Sciences S.r.l. ,Neurimmune Holding AG ,Northwest Biotherapeutics, Inc. ,Novartis AG ,NovaTarg Therapeutics, Inc ,Noviga Research AB ,NuCana BioMed Limited ,Oasmia Pharmaceutical AB ,OBI Pharma, Inc. ,Omeros Corporation ,Omnitura Therapeutics Inc. ,OncBioMune Pharmaceuticals Inc. ,Oncobiologics, Inc. ,Oncodesign SA ,OncoHoldings, Inc. ,Oncolix, Inc. ,Oncolytics Biotech Inc. ,OncoMed Pharmaceuticals, Inc. ,Oncopeptides AB ,OncoTartis, Inc. ,Oncternal Therapeutics, Inc. ,Ono Pharmaceutical Co., Ltd. ,Optimum Therapeutics, LLC ,ORCA Therapeutics B.V. ,OSE Immunotherapeutics ,Otsuka Holdings Co., Ltd. ,Oxford BioMedica Plc ,Pangaea Biotech, S.L. ,Panther Biotechnology, Inc. ,PDS Biotechnology Corporation ,PEP-Therapy SAS ,Pfizer Inc. ,Pharma Mar, S.A. ,Pharmacyclics, Inc. ,PharmAust Limited ,Pharmicell Co., Ltd. ,Polaris Pharmaceuticals, Inc. ,Precision Biologics, Inc. ,Prima BioMed Ltd. ,Progen Pharmaceuticals Limited ,PsiOxus Therapeutics Limited ,Puma Biotechnology, Inc. ,Quest PharmaTech Inc. ,Recepta Biopharma S.A. ,Rexahn Pharmaceuticals, Inc. ,Rgenix, Inc. ,Richter Gedeon Nyrt. ,Rigontec GmbH ,Rosetta Genomics, Ltd. ,Sanofi ,Sanofi Pasteur SA ,Sapvax ,Satt Nord SAS ,Sellas Inc. ,Shenzen SiBiono GeneTech Co., Ltd. ,Sigma-Tau S.p.A. ,Soricimed Biopharma Inc. ,Sorrento Therapeutics, Inc. ,Sotio a.s. ,Spectrum Pharmaceuticals, Inc. ,Sphaera Pharma Pvt. Ltd. ,Starpharma Holdings Limited ,Sumitomo Dainippon Pharma Co., Ltd. ,Sun Pharma Advanced Research Company Ltd. ,Supratek Pharma Inc. ,Susavion Biosciences, Inc. ,Symic Biomedical, Inc. ,Syndax Pharmaceuticals, Inc. ,Synta Pharmaceuticals Corp. ,TaiRx, Inc. ,Takeda Pharmaceutical Company Limited ,Takis S.r.l. ,TapImmune Inc. ,Tara Immuno-Oncology Therapeutics LLC ,Targovax AS ,Tesaro, Inc. ,TetraLogic Pharmaceuticals ,Theravectys SA ,TVAX Biomedical, Inc. ,TyrNovo Ltd. ,Tyrogenex, Inc. ,ValiRx Plc ,Vascular Biogenics Ltd. ,VentiRx Pharmaceuticals, Inc. ,Verastem, Inc. ,VG Life Sciences, Inc. ,ViiV Healthcare Limited ,VioQuest Pharmaceuticals, Inc. ,ViraTherapeutics GmbH ,Vyriad ,Zensun (Shanghai) Sci & Tech Co., Ltd.

Inquire more about this research report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=647176

The report provides comprehensive information on the therapeutics under development for Ovarian Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Ovarian Cancer and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

• The report provides a snapshot of the global therapeutic landscape of Ovarian Cancer
• The report reviews pipeline therapeutics for Ovarian Cancer by companies and universities/research institutes based on information derived from company and industry-specific sources
• The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved Ovarian Cancer therapeutics and enlists all their major and minor projects
• The report assesses Ovarian Cancer therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
• The report summarizes all the dormant and discontinued pipeline projects
• The report reviews latest news related to pipeline therapeutics for Ovarian Cancer

Complete research report 1780 pages with TOC is available at http://www.rnrmarketresearch.com/ovarian-cancer-pipeline-review-h1-2016-market-report.html

Contact Info:
Name: Ritesh Tiwari
Email: Send Email
Organization: RnR Market Research
Address: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India
Phone: +1888 391 54 41
Website: http://www.rnrmarketresearch.com/

Release ID: 125574